scispace - formally typeset
J

Jai Seth

Researcher at UCL Institute of Neurology

Publications -  33
Citations -  276

Jai Seth is an academic researcher from UCL Institute of Neurology. The author has contributed to research in topics: Overactive bladder & Percutaneous tibial nerve stimulation. The author has an hindex of 8, co-authored 31 publications receiving 220 citations. Previous affiliations of Jai Seth include St Thomas' Hospital & St George's Hospital.

Papers
More filters
Journal ArticleDOI

Nerve growth factor (NGF): a potential urinary biomarker for overactive bladder syndrome (OAB)?

TL;DR: The protein of interest here is nerve growth factor (NGF) and it has been shown to be a dynamic molecule in the bladder of patients with OAB, but the specificity of this as a potential urinary biomarker for OAB is questioned.
Journal ArticleDOI

Neurogenic Detrusor Overactivity in Patients With Spinal Cord Injury: Evaluation and Management

TL;DR: This article reviews the assessment and management of neurogenic detrusor overactivity, with a particular focus on articles from the recent literature.
Journal ArticleDOI

Outcomes following percutaneous tibial nerve stimulation (PTNS) treatment for neurogenic and idiopathic overactive bladder

TL;DR: Percutaneous tibial nerve stimulation appears to be a possible promising alternative for patients with neurological disorder reporting overactive bladder symptoms who find first-line treatments either ineffective or intolerable, however, a properly designed study is required to address safety and efficacy.
Journal ArticleDOI

Nocturia in Patients With Parkinson's Disease

TL;DR: Evaluated lower urinary tract (LUT) symptoms in patients with PD reporting nocturia using standardized validated questionnaires and bladder diaries and to assess the impact ofNocturia on quality of life and sleep.
Journal ArticleDOI

Feasibility of using a novel non-invasive ambulatory tibial nerve stimulation device for the home-based treatment of overactive bladder symptoms.

TL;DR: This novel ambulatory transcutaneous TNS (TTNS) device is safe and acceptable for use in patients reporting OAB symptoms as a form of home-based neuromodulation and a larger study is required to confirm clinical efficacy.